Journal of Nuclear Medicine: 63 (3)

About the Cover

March 1, 2022; Volume 63,Issue 3

A

Aarntzen, Erik H.J.G.
1. You have access
  Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies
  Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van, den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 359-361; DOI: https://doi.org/10.2967/jnumed.121.262622
Addeo, Pietro
1. You have access
  Value of ⁶⁸Ga-DOTATOC and Carbidopa-Assisted ¹⁸F-DOPA PET/CT for Insulinoma Localization
  Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
Afshar-Oromieh, Ali
1. You have access
  Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
  George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972
Åkesson, Anna
1. You have access
  Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with ¹⁷⁷Lu-DOTATATE
  Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 399-405; DOI: https://doi.org/10.2967/jnumed.121.262069
Almaguel, Frankis
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192

B

Bahce, Idris
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
Bahri, Shadfar
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Banerjee, Indraneel
1. You have access
  ⁶⁸Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
Barca, Cristina
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279
Baum, Richard P.
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Becker, Juergen C.
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Bénard, François
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
Ben Haim, Simona
1. Open Access
  Lessons Learned from Post–COVID-19 Vaccination PET/CT Studies
  Marina Orevi, Alexandre Chicheportiche and Simona Ben Haim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 453-460; DOI: https://doi.org/10.2967/jnumed.121.262348
Berliner, Christoph
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Berman, Daniel
1. You have access
  Latest Advances in Multimodality Imaging of Aortic Stenosis
  Evangelos Tzolos, Jacek Kwiecinski, Daniel Berman, Piotr Slomka, David E. Newby and Marc R. Dweck
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 353-358; DOI: https://doi.org/10.2967/jnumed.121.262304
Blankenstein, Oliver
1. You have access
  Reply: ⁶⁸Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167
Boellaard, Ronald
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
2. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117
Bögemann, Martin
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Bohnen, Nicolaas I.
1. You have access
  Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography
  Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Nicholas D’Cruz and Martijn L.T.M. Müller
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 438-445; DOI: https://doi.org/10.2967/jnumed.121.261939
Boss, Marti
1. You have access
  Reply: ⁶⁸Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167
Boursier, Caroline
1. You have access
  Value of ⁶⁸Ga-DOTATOC and Carbidopa-Assisted ¹⁸F-DOPA PET/CT for Insulinoma Localization
  Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
Braat, Arthur J.A.T.
1. You have access
  Intraarterial Administration Boosts ¹⁷⁷Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  Evert-Jan P.A. Vonken, Rutger C.G. Bruijnen, Tom J. Snijders, Tatjana Seute, Marnix G.E.H. Lam, Bart de Keizer and Arthur J.A.T. Braat
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 406-409; DOI: https://doi.org/10.2967/jnumed.121.262491
Bratanovic, Ivica J.
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
Brenner, Winfried
1. You have access
  Reply: ⁶⁸Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167
Brug, de
1. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117
Bruijnen, Rutger C.G.
1. You have access
  Intraarterial Administration Boosts ¹⁷⁷Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  Evert-Jan P.A. Vonken, Rutger C.G. Bruijnen, Tom J. Snijders, Tatjana Seute, Marnix G.E.H. Lam, Bart de Keizer and Arthur J.A.T. Braat
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 406-409; DOI: https://doi.org/10.2967/jnumed.121.262491
Buitinga, Mijke
1. You have access
  Reply: ⁶⁸Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167
Byrne, Christina
1. Open Access
  Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
  Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer and Philip Hasbak
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 431-437; DOI: https://doi.org/10.2967/jnumed.121.261970

C

Calais, Jérémie
1. You have access
  Health Care and Nuclear Medicine in France
  Dominique Le Guludec, Johannes Czernin and Jérémie Calais
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 327-330; DOI: https://doi.org/10.2967/jnumed.122.263863
Carlsen, Esben A.
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Catalano, Onofrio A.
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
Catana, Ciprian
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
Chantadisai, Maythinee
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Chevalier, Elodie
1. You have access
  Value of ⁶⁸Ga-DOTATOC and Carbidopa-Assisted ¹⁸F-DOPA PET/CT for Insulinoma Localization
  Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
Chicheportiche, Alexandre
1. Open Access
  Lessons Learned from Post–COVID-19 Vaccination PET/CT Studies
  Marina Orevi, Alexandre Chicheportiche and Simona Ben Haim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 453-460; DOI: https://doi.org/10.2967/jnumed.121.262348
Colpo, Nadine
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
Czernin, Johannes
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
2. You have access
  Health Care and Nuclear Medicine in France
  Dominique Le Guludec, Johannes Czernin and Jérémie Calais
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 327-330; DOI: https://doi.org/10.2967/jnumed.122.263863

D

D’Cruz, Nicholas
1. You have access
  Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography
  Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Nicholas D’Cruz and Martijn L.T.M. Müller
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 438-445; DOI: https://doi.org/10.2967/jnumed.121.261939
Deek, Matthew
1. You have access
  The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging
  Philip Sutera, Ryan M. Phillips, Matthew Deek, Gokhan Ozyigit, Cem Onal and Phuoc T. Tran
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 339-341; DOI: https://doi.org/10.2967/jnumed.121.263684
de Langen, Adrianus J.
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
de Vet, Henrica C.W.
1. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117
de Wit-van der Veen, Berlinda J.
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
Ding, Jie
1. You have access
  Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using ⁶⁸Ga-Pentixafor
  Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
Doot, Robert K.
1. You have access
  Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
  Austin R. Pantel, Varsha Viswanath, Mark Muzi, Robert K. Doot and David A. Mankoff
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 342-352; DOI: https://doi.org/10.2967/jnumed.121.263518
Dunne, Mark J.
1. You have access
  ⁶⁸Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
Dweck, Marc R.
1. You have access
  Latest Advances in Multimodality Imaging of Aortic Stenosis
  Evangelos Tzolos, Jacek Kwiecinski, Daniel Berman, Piotr Slomka, David E. Newby and Marc R. Dweck
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 353-358; DOI: https://doi.org/10.2967/jnumed.121.262304

E

Eertink, Jakoba J.
1. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117
Eismant, Alexander
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Ellinger, Jörg
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Essler, Markus
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Estebanez, Maria Salomon
1. You have access
  ⁶⁸Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
Ezziddin, Samer
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240

F

Faber, Cornelius
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279
Fendler, Wolfgang P.
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Ferdinandus, Justin
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Flux, Glenn D.
1. You have access
  RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 2—Data Analysis and Dosimetry
  Michael G. Stabin, Richard E. Wendt and Glenn D. Flux
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 485-492; DOI: https://doi.org/10.2967/jnumed.121.262034
Foray, Claudia
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279
Fougère, Christian la
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Fürstner, Markus
1. You have access
  Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
  George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972

G

Gleisner, Katarina Sjögreen
1. You have access
  Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with ¹⁷⁷Lu-DOTATATE
  Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 399-405; DOI: https://doi.org/10.2967/jnumed.121.262069
Gotthardt, Martin
1. You have access
  Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies
  Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van, den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 359-361; DOI: https://doi.org/10.2967/jnumed.121.262622
2. You have access
  Reply: ⁶⁸Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167
Grønbæk, Henning
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Guludec, Dominique Le
1. You have access
  Health Care and Nuclear Medicine in France
  Dominique Le Guludec, Johannes Czernin and Jérémie Calais
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 327-330; DOI: https://doi.org/10.2967/jnumed.122.263863
Gustafsson, Johan
1. You have access
  Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with ¹⁷⁷Lu-DOTATATE
  Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 399-405; DOI: https://doi.org/10.2967/jnumed.121.262069

H

Hacker, Marcus
1. You have access
  Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using ⁶⁸Ga-Pentixafor
  Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
Hadaschik, Eva
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Hasbak, Philip
1. Open Access
  Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
  Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer and Philip Hasbak
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 431-437; DOI: https://doi.org/10.2967/jnumed.121.261970
Hentschel, Michael
1. You have access
  Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
  George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972
Hermann, Sven
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279
Herrmann, Ken
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Heskamp, Sandra
1. You have access
  Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies
  Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van, den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 359-361; DOI: https://doi.org/10.2967/jnumed.121.262622
Heuvel, den
1. You have access
  Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies
  Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van, den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 359-361; DOI: https://doi.org/10.2967/jnumed.121.262622
Hoehne, Aileen
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Hoekstra, Otto S.
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
2. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117
Huisman, Marc C.
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
Huo, Li
1. You have access
  Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using ⁶⁸Ga-Pentixafor
  Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
Hurry, Preetee Kapisha
1. Open Access
  Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
  Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer and Philip Hasbak
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 431-437; DOI: https://doi.org/10.2967/jnumed.121.261970

I

Im, Changkeun
1. Open Access
  PET Tracing of Biodistribution for Orally Administered ⁶⁴Cu-Labeled Polystyrene in Mice
  Changkeun Im, Hyeongi Kim, Javeria Zaheer, Jung Young Kim, Yong-Jin Lee, Choong Mo Kang and Jin Su Kim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 461-467; DOI: https://doi.org/10.2967/jnumed.120.256982
Imperiale, Alessio
1. You have access
  Value of ⁶⁸Ga-DOTATOC and Carbidopa-Assisted ¹⁸F-DOPA PET/CT for Insulinoma Localization
  Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
Iversen, Peter
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Izquierdo-Garcia, David
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032

J

Jacobs, Andreas H.
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279

K

Kamen, Ali
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
Kang, Choong Mo
1. Open Access
  PET Tracing of Biodistribution for Orally Administered ⁶⁴Cu-Labeled Polystyrene in Mice
  Changkeun Im, Hyeongi Kim, Javeria Zaheer, Jung Young Kim, Yong-Jin Lee, Choong Mo Kang and Jin Su Kim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 461-467; DOI: https://doi.org/10.2967/jnumed.120.256982
Keizer, Bart de
1. You have access
  Intraarterial Administration Boosts ¹⁷⁷Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  Evert-Jan P.A. Vonken, Rutger C.G. Bruijnen, Tom J. Snijders, Tatjana Seute, Marnix G.E.H. Lam, Bart de Keizer and Arthur J.A.T. Braat
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 406-409; DOI: https://doi.org/10.2967/jnumed.121.262491
Kiliaan, Amanda J.
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279
Kim, Hyeongi
1. Open Access
  PET Tracing of Biodistribution for Orally Administered ⁶⁴Cu-Labeled Polystyrene in Mice
  Changkeun Im, Hyeongi Kim, Javeria Zaheer, Jung Young Kim, Yong-Jin Lee, Choong Mo Kang and Jin Su Kim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 461-467; DOI: https://doi.org/10.2967/jnumed.120.256982
Kim, Jin Su
1. Open Access
  PET Tracing of Biodistribution for Orally Administered ⁶⁴Cu-Labeled Polystyrene in Mice
  Changkeun Im, Hyeongi Kim, Javeria Zaheer, Jung Young Kim, Yong-Jin Lee, Choong Mo Kang and Jin Su Kim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 461-467; DOI: https://doi.org/10.2967/jnumed.120.256982
Kim, Jung Young
1. Open Access
  PET Tracing of Biodistribution for Orally Administered ⁶⁴Cu-Labeled Polystyrene in Mice
  Changkeun Im, Hyeongi Kim, Javeria Zaheer, Jung Young Kim, Yong-Jin Lee, Choong Mo Kang and Jin Su Kim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 461-467; DOI: https://doi.org/10.2967/jnumed.120.256982
Kjaer, Andreas
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
2. Open Access
  Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
  Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer and Philip Hasbak
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 431-437; DOI: https://doi.org/10.2967/jnumed.121.261970
Klode, Joachim
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Knigge, Ulrich
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Kramer, Gero
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Kulkarni, Harshad R.
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Kuo, Hsiou‐Ting
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
Kurzidem, Sabine
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Kwiecinski, Jacek
1. You have access
  Latest Advances in Multimodality Imaging of Aortic Stenosis
  Evangelos Tzolos, Jacek Kwiecinski, Daniel Berman, Piotr Slomka, David E. Newby and Marc R. Dweck
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 353-358; DOI: https://doi.org/10.2967/jnumed.121.262304

L

Lam, Marnix G.E.H.
1. You have access
  Intraarterial Administration Boosts ¹⁷⁷Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  Evert-Jan P.A. Vonken, Rutger C.G. Bruijnen, Tom J. Snijders, Tatjana Seute, Marnix G.E.H. Lam, Bart de Keizer and Arthur J.A.T. Braat
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 406-409; DOI: https://doi.org/10.2967/jnumed.121.262491
Lassen, Martin Lyngby
1. Open Access
  Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
  Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer and Philip Hasbak
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 431-437; DOI: https://doi.org/10.2967/jnumed.121.261970
Lee, Yong-Jin
1. Open Access
  PET Tracing of Biodistribution for Orally Administered ⁶⁴Cu-Labeled Polystyrene in Mice
  Changkeun Im, Hyeongi Kim, Javeria Zaheer, Jung Young Kim, Yong-Jin Lee, Choong Mo Kang and Jin Su Kim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 461-467; DOI: https://doi.org/10.2967/jnumed.120.256982
Leon, Diva D. De
1. You have access
  ⁶⁸Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
Li, Xiang
1. You have access
  Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using ⁶⁸Ga-Pentixafor
  Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
Lin, Kuo‐Shyan
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
Livingstone, Elisabeth
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Loft, Mathias
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Lueckerath, Katharina
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Lugtenburg, Pieternella J.
1. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117

M

Maffey-Steffan, Johanna
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Malpica, Norberto
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
Mankoff, David A.
1. You have access
  Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
  Austin R. Pantel, Varsha Viswanath, Mark Muzi, Robert K. Doot and David A. Mankoff
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 342-352; DOI: https://doi.org/10.2967/jnumed.121.263518
McEwan, Sandy
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Mell, Loren K.
1. You have access
  Reply: Adding Nontumor Radiomic Features to the Prognostic Model Is Bothersome but Useful
  Tahir I. Yusufaly and Loren K. Mell
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 495; DOI: https://doi.org/10.2967/jnumed.121.263730
Meltzer, Jeffrey
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Merkens, Helen
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
Miller, Colin G.
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Miyahira, Andrea K.
1. You have access
  The History of Prostate-Specific Membrane Antigen as a Theranostic Target in Prostate Cancer: The Cornerstone Role of the Prostate Cancer Foundation
  Andrea K. Miyahira and Howard R. Soule
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 331-338; DOI: https://doi.org/10.2967/jnumed.121.262997
Mohnike, Klaus
1. You have access
  ⁶⁸Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
Mohnike, Konrad
1. You have access
  ⁶⁸Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
Mohnike, Wolfgang
1. You have access
  ⁶⁸Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
Morales, Manuel A.
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
Mueller, Dirk
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Müller, Martijn L.T.M.
1. You have access
  Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography
  Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Nicholas D’Cruz and Martijn L.T.M. Müller
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 438-445; DOI: https://doi.org/10.2967/jnumed.121.261939
Muzi, Mark
1. You have access
  Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
  Austin R. Pantel, Varsha Viswanath, Mark Muzi, Robert K. Doot and David A. Mankoff
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 342-352; DOI: https://doi.org/10.2967/jnumed.121.263518

N

Newby, David E.
1. You have access
  Latest Advances in Multimodality Imaging of Aortic Stenosis
  Evangelos Tzolos, Jacek Kwiecinski, Daniel Berman, Piotr Slomka, David E. Newby and Marc R. Dweck
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 353-358; DOI: https://doi.org/10.2967/jnumed.121.262304
Ng, Thomas S.C.
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
Niemeijer, Anna-Larissa N.
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
Nordquist, Luke
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240

O

Onal, Cem
1. You have access
  The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging
  Philip Sutera, Ryan M. Phillips, Matthew Deek, Gokhan Ozyigit, Cem Onal and Phuoc T. Tran
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 339-341; DOI: https://doi.org/10.2967/jnumed.121.263684
Oprea-Lager, Daniela E.
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
Orevi, Marina
1. Open Access
  Lessons Learned from Post–COVID-19 Vaccination PET/CT Studies
  Marina Orevi, Alexandre Chicheportiche and Simona Ben Haim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 453-460; DOI: https://doi.org/10.2967/jnumed.121.262348
Osterkamp, Frank
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Ouvrard, Eric
1. You have access
  Value of ⁶⁸Ga-DOTATOC and Carbidopa-Assisted ¹⁸F-DOPA PET/CT for Insulinoma Localization
  Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
Ozyigit, Gokhan
1. You have access
  The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging
  Philip Sutera, Ryan M. Phillips, Matthew Deek, Gokhan Ozyigit, Cem Onal and Phuoc T. Tran
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 339-341; DOI: https://doi.org/10.2967/jnumed.121.263684

P

Paganelli, Giovanni
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Pantel, Austin R.
1. You have access
  Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
  Austin R. Pantel, Varsha Viswanath, Mark Muzi, Robert K. Doot and David A. Mankoff
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 342-352; DOI: https://doi.org/10.2967/jnumed.121.263518
Peer, Avivit
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Pfaehler, Elisabeth A.G.
1. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117
Phillips, Ryan M.
1. You have access
  The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging
  Philip Sutera, Ryan M. Phillips, Matthew Deek, Gokhan Ozyigit, Cem Onal and Phuoc T. Tran
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 339-341; DOI: https://doi.org/10.2967/jnumed.121.263684
Powell, Christine
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Prasad, Sonal
1. You have access
  Reply: ⁶⁸Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167
Prasad, Vikas
1. You have access
  Reply: ⁶⁸Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167
Prenosil, George A.
1. You have access
  Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
  George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972

R

Reaungamornrat, Ja
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
Reineke, Ulrich
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Robiller, Franz C.
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Rohban, Thomas
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Rominger, Axel
1. You have access
  Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
  George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972
Roth, Daniel
1. You have access
  Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with ¹⁷⁷Lu-DOTATATE
  Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 399-405; DOI: https://doi.org/10.2967/jnumed.121.262069
Rottenburger, Christof
1. You have access
  Reply: ⁶⁸Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167

S

Sahakian, Nicolas
1. You have access
  Value of ⁶⁸Ga-DOTATOC and Carbidopa-Assisted ¹⁸F-DOPA PET/CT for Insulinoma Localization
  Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
Sajjan, Rakesh
1. You have access
  ⁶⁸Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
Sanchez-Catasus, Carlos A.
1. You have access
  Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography
  Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Nicholas D’Cruz and Martijn L.T.M. Müller
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 438-445; DOI: https://doi.org/10.2967/jnumed.121.261939
Sandström, Per
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Sari, Hasan
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
2. You have access
  Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
  George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972
Sartor, Oliver
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Schadendorf, Dirk
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Schäfers, Michael
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279
Schmedes, Anne Vibeke
1. Open Access
  Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
  Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer and Philip Hasbak
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 431-437; DOI: https://doi.org/10.2967/jnumed.121.261970
Schuchardt, Christiane
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Sebag, Frédéric
1. You have access
  Value of ⁶⁸Ga-DOTATOC and Carbidopa-Assisted ¹⁸F-DOPA PET/CT for Insulinoma Localization
  Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
Seute, Tatjana
1. You have access
  Intraarterial Administration Boosts ¹⁷⁷Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  Evert-Jan P.A. Vonken, Rutger C.G. Bruijnen, Tom J. Snijders, Tatjana Seute, Marnix G.E.H. Lam, Bart de Keizer and Arthur J.A.T. Braat
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 406-409; DOI: https://doi.org/10.2967/jnumed.121.262491
Shah, Pratik
1. You have access
  Reply: ⁶⁸Ga NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Vikas Prasad, Marti Boss, Christof Rottenburger, Winfried Brenner, Oliver Blankenstein, Sonal Prasad, Mijke Buitinga, Pratik Shah and Martin Gotthardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493-494; DOI: https://doi.org/10.2967/jnumed.121.263167
Sheykhzade, Majid
1. Open Access
  Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
  Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer and Philip Hasbak
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 431-437; DOI: https://doi.org/10.2967/jnumed.121.261970
Shi, Kuangyu
1. You have access
  Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard
  George A. Prenosil, Hasan Sari, Markus Fürstner, Ali Afshar-Oromieh, Kuangyu Shi, Axel Rominger and Michael Hentschel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 476-484; DOI: https://doi.org/10.2967/jnumed.121.261972
Singh, Aviral
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Slomka, Piotr
1. You have access
  Latest Advances in Multimodality Imaging of Aortic Stenosis
  Evangelos Tzolos, Jacek Kwiecinski, Daniel Berman, Piotr Slomka, David E. Newby and Marc R. Dweck
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 353-358; DOI: https://doi.org/10.2967/jnumed.121.262304
Smerling, Christiane
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Smit, Egbert F.
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
Snijders, Tom J.
1. You have access
  Intraarterial Administration Boosts ¹⁷⁷Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  Evert-Jan P.A. Vonken, Rutger C.G. Bruijnen, Tom J. Snijders, Tatjana Seute, Marnix G.E.H. Lam, Bart de Keizer and Arthur J.A.T. Braat
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 406-409; DOI: https://doi.org/10.2967/jnumed.121.262491
Song, Daniel Y.
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Soule, Howard R.
1. You have access
  The History of Prostate-Specific Membrane Antigen as a Theranostic Target in Prostate Cancer: The Cornerstone Role of the Prostate Cancer Foundation
  Andrea K. Miyahira and Howard R. Soule
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 331-338; DOI: https://doi.org/10.2967/jnumed.121.262997
Stabin, Michael G.
1. You have access
  RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 2—Data Analysis and Dosimetry
  Michael G. Stabin, Richard E. Wendt and Glenn D. Flux
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 485-492; DOI: https://doi.org/10.2967/jnumed.121.262034
States, Lisa J.
1. You have access
  ⁶⁸Ga-NODAGA-Exendin-4 PET Scanning for Focal Congenital Hyperinsulinism: Need for Replication
  Indraneel Banerjee, Rakesh Sajjan, Maria Salomon Estebanez, Mark J. Dunne, Konrad Mohnike, Wolfgang Mohnike, Lisa J. States, Diva D. De Leon and Klaus Mohnike
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 493; DOI: https://doi.org/10.2967/jnumed.121.262984
Sundlöv, Anna
1. You have access
  Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with ¹⁷⁷Lu-DOTATATE
  Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 399-405; DOI: https://doi.org/10.2967/jnumed.121.262069
Sutera, Philip
1. You have access
  The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging
  Philip Sutera, Ryan M. Phillips, Matthew Deek, Gokhan Ozyigit, Cem Onal and Phuoc T. Tran
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 339-341; DOI: https://doi.org/10.2967/jnumed.121.263684
Sylvester, John
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240

T

Taïeb, David
1. You have access
  Value of ⁶⁸Ga-DOTATOC and Carbidopa-Assisted ¹⁸F-DOPA PET/CT for Insulinoma Localization
  Alessio Imperiale, Caroline Boursier, Nicolas Sahakian, Eric Ouvrard, Elodie Chevalier, Frédéric Sebag, Pietro Addeo and David Taïeb
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 384-388; DOI: https://doi.org/10.2967/jnumed.121.262401
Tennvall, Jan
1. You have access
  Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with ¹⁷⁷Lu-DOTATATE
  Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 399-405; DOI: https://doi.org/10.2967/jnumed.121.262069
Thunnissen, Erik
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
Tong, Anli
1. You have access
  Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using ⁶⁸Ga-Pentixafor
  Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
Torrado-Carvajal, Angel
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
Tran, Phuoc T.
1. You have access
  The Promise of Metastasis-Directed Therapy for Oligometastatic Prostate Cancer: Going Beneath the Surface with Molecular Imaging
  Philip Sutera, Ryan M. Phillips, Matthew Deek, Gokhan Ozyigit, Cem Onal and Phuoc T. Tran
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 339-341; DOI: https://doi.org/10.2967/jnumed.121.263684
Tzolos, Evangelos
1. You have access
  Latest Advances in Multimodality Imaging of Aortic Stenosis
  Evangelos Tzolos, Jacek Kwiecinski, Daniel Berman, Piotr Slomka, David E. Newby and Marc R. Dweck
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 353-358; DOI: https://doi.org/10.2967/jnumed.121.262304

U

Ugurel, Selma
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Uribe, Carlos
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758

V

van, Michel M.
1. You have access
  Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies
  Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van, den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 359-361; DOI: https://doi.org/10.2967/jnumed.121.262622
van, Tim
1. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117
van Dongen, Guus A.M.S.
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926
van Herpen, Carla M.L.
1. You have access
  Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies
  Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van, den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 359-361; DOI: https://doi.org/10.2967/jnumed.121.262622
Vera-Olmos, Javier
1. You have access
  Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images
  Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen and Ciprian Catana
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 468-475; DOI: https://doi.org/10.2967/jnumed.120.261032
Verhoeff, Sarah R.
1. You have access
  Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies
  Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van, den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 359-361; DOI: https://doi.org/10.2967/jnumed.121.262622
Verholen, Frank
1. Open Access
  ¹⁷⁷Lu-Prostate-Specific Membrane Antigen Ligand After ²²³Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience
  Oliver Sartor, Christian la Fougère, Markus Essler, Samer Ezziddin, Gero Kramer, Jörg Ellinger, Luke Nordquist, John Sylvester, Giovanni Paganelli, Avivit Peer, Martin Bögemann, Jeffrey Meltzer, Per Sandström, Frank Verholen and Daniel Y. Song
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 410-414; DOI: https://doi.org/10.2967/jnumed.121.262240
Virgolini, Irene
1. Open Access
  A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for ⁶⁸Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors
  Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Esben A. Carlsen, Mathias Loft, Ulrich Knigge, Johanna Maffey-Steffan, Christine Powell, Colin G. Miller, Thomas Rohban, Sandy McEwan and Johannes Czernin
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 376-383; DOI: https://doi.org/10.2967/jnumed.121.261936
Viswanath, Varsha
1. You have access
  Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
  Austin R. Pantel, Varsha Viswanath, Mark Muzi, Robert K. Doot and David A. Mankoff
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 342-352; DOI: https://doi.org/10.2967/jnumed.121.263518
Vonken, Evert-Jan P.A.
1. You have access
  Intraarterial Administration Boosts ¹⁷⁷Lu-HA-DOTATATE Accumulation in Salvage Meningioma Patients
  Evert-Jan P.A. Vonken, Rutger C.G. Bruijnen, Tom J. Snijders, Tatjana Seute, Marnix G.E.H. Lam, Bart de Keizer and Arthur J.A.T. Braat
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 406-409; DOI: https://doi.org/10.2967/jnumed.121.262491
Vugts, Daniëlle J.
1. You have access
  Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer
  Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 362-367; DOI: https://doi.org/10.2967/jnumed.121.261926

W

Wachsmuth, Lydia
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279
Wahl, Richard L.
1. You have access
  SNMMI Leadership Update: Call the Nuclear Oncologist
  Richard L. Wahl
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 15N;
Warfvinge, Carl Fredrik
1. You have access
  Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with ¹⁷⁷Lu-DOTATATE
  Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall and Katarina Sjögreen Gleisner
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 399-405; DOI: https://doi.org/10.2967/jnumed.121.262069
Wen, Jin
1. You have access
  Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using ⁶⁸Ga-Pentixafor
  Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
Wendt, Richard E.
1. You have access
  RADAR Guide: Standard Methods for Calculating Radiation Doses for Radiopharmaceuticals, Part 2—Data Analysis and Dosimetry
  Michael G. Stabin, Richard E. Wendt and Glenn D. Flux
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 485-492; DOI: https://doi.org/10.2967/jnumed.121.262034
Westdorp, Harm
1. You have access
  Toward a Better Understanding of Immune Checkpoint Inhibitor Radiolabeled PET Imaging Studies
  Harm Westdorp, Sarah R. Verhoeff, Martin Gotthardt, Carla M.L. van Herpen, Michel M. van, den Heuvel, Sandra Heskamp and Erik H.J.G. Aarntzen
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 359-361; DOI: https://doi.org/10.2967/jnumed.121.262622
Wiegers, Sanne E.
1. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117
Wiesmann, Maximilian
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279
Wissenberg, Mads
1. Open Access
  Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia
  Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer and Philip Hasbak
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 431-437; DOI: https://doi.org/10.2967/jnumed.121.261970

Y

Yusufaly, Tahir I.
1. You have access
  Reply: Adding Nontumor Radiomic Features to the Prognostic Model Is Bothersome but Useful
  Tahir I. Yusufaly and Loren K. Mell
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 495; DOI: https://doi.org/10.2967/jnumed.121.263730

Z

Zaheer, Javeria
1. Open Access
  PET Tracing of Biodistribution for Orally Administered ⁶⁴Cu-Labeled Polystyrene in Mice
  Changkeun Im, Hyeongi Kim, Javeria Zaheer, Jung Young Kim, Yong-Jin Lee, Choong Mo Kang and Jin Su Kim
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 461-467; DOI: https://doi.org/10.2967/jnumed.120.256982
Zboralski, Dirk
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Zeisler, Jutta
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
Zhang, Bin
1. You have access
  Adding Nontumor Radiomic Features to the Prognostic Model Is Bothersome but Useful
  Lu Zhang and Bin Zhang
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 494-495; DOI: https://doi.org/10.2967/jnumed.121.263479
Zhang, Chengcheng
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
Zhang, Hui
1. You have access
  Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using ⁶⁸Ga-Pentixafor
  Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
Zhang, Jingjing
1. Open Access
  Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results
  Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling and Harshad R. Kulkarni
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 415-423; DOI: https://doi.org/10.2967/jnumed.120.259192
Zhang, Lu
1. You have access
  Adding Nontumor Radiomic Features to the Prognostic Model Is Bothersome but Useful
  Lu Zhang and Bin Zhang
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 494-495; DOI: https://doi.org/10.2967/jnumed.121.263479
Zhang, Yushi
1. You have access
  Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using ⁶⁸Ga-Pentixafor
  Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo and Xiang Li
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 368-375; DOI: https://doi.org/10.2967/jnumed.121.261964
Zhang, Zhengxing
1. You have access
  A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer
  Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin and François Bénard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 424-430; DOI: https://doi.org/10.2967/jnumed.120.257758
Zijlstra, Josée M.
1. You have access
  Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet and Ronald Boellaard
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 389-395; DOI: https://doi.org/10.2967/jnumed.121.262117
Zimmer, Lisa
1. You have access
  Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma
  Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker and Selma Ugurel
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 396-398; DOI: https://doi.org/10.2967/jnumed.121.262344
Zinnhardt, Bastian
1. Open Access
  A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke
  Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs and Bastian Zinnhardt
  
  Journal of Nuclear Medicine March 1, 2022, 63 (3) 446-452; DOI: https://doi.org/10.2967/jnumed.121.262279

Main menu

User menu

Search

About the Cover

A

Aarntzen, Erik H.J.G.

Addeo, Pietro

Afshar-Oromieh, Ali

Åkesson, Anna

Almaguel, Frankis

B

Bahce, Idris

Bahri, Shadfar

Banerjee, Indraneel

Barca, Cristina

Baum, Richard P.

Becker, Juergen C.

Bénard, François

Ben Haim, Simona

Berliner, Christoph

Berman, Daniel

Blankenstein, Oliver

Boellaard, Ronald

Bögemann, Martin

Bohnen, Nicolaas I.

Boss, Marti

Boursier, Caroline

Braat, Arthur J.A.T.

Bratanovic, Ivica J.

Brenner, Winfried

Brug, de

Bruijnen, Rutger C.G.

Buitinga, Mijke

Byrne, Christina

C

Calais, Jérémie

Carlsen, Esben A.

Catalano, Onofrio A.

Catana, Ciprian

Chantadisai, Maythinee

Chevalier, Elodie

Chicheportiche, Alexandre

Colpo, Nadine

Czernin, Johannes

D

D’Cruz, Nicholas

Deek, Matthew

de Langen, Adrianus J.

de Vet, Henrica C.W.

de Wit-van der Veen, Berlinda J.

Ding, Jie

Doot, Robert K.

Dunne, Mark J.

Dweck, Marc R.

E

Eertink, Jakoba J.

Eismant, Alexander

Ellinger, Jörg

Essler, Markus

Estebanez, Maria Salomon

Ezziddin, Samer

F

Faber, Cornelius

Fendler, Wolfgang P.

Ferdinandus, Justin

Flux, Glenn D.

Foray, Claudia

Fougère, Christian la

Fürstner, Markus

G

Gleisner, Katarina Sjögreen

Gotthardt, Martin

Grønbæk, Henning

Guludec, Dominique Le

Gustafsson, Johan

H

Hacker, Marcus

Hadaschik, Eva

Hasbak, Philip

Hentschel, Michael